No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
SMMT241220P18500
- 0.60
- -0.35-36.84%
15min DelayClose Dec 20 16:00 ET
0.60High0.45Low
0.45Open0.95Pre Close13 Volume70 Open Interest18.50Strike Price735.00Turnover0.00%IV-0.17%PremiumDec 20, 2024Expiry Date0.63Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma8.03Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Why Did Summit Therapeutics Inc. (SMMT) Jump Yesterday?
Where Will Summit Therapeutics Be in 5 Years?
Summit Therapeutics Shares Are Trading Higher. The Stock May Be Moving in Sympathy With Neurocrine Biosciences Which Received FDA Approval for CRESNESSITY.
Watching Summit Therapeutics; Traders Circulate Newsletter Mention
How Is The Market Feeling About Summit Therapeutics?
Summit Therapeutics Initiated at Overweight by Wells Fargo